LOINC_NUM
stringlengths 3
8
| COMPONENT
stringlengths 2
246
| PROPERTY
stringlengths 1
29
| TIME_ASPCT
stringlengths 1
15
| SYSTEM
stringlengths 1
106
| SCALE_TYP
stringclasses 10
values | METHOD_TYP
stringlengths 1
57
⌀ | CLASS
stringlengths 2
24
| CLASSTYPE
int64 1
4
| LONG_COMMON_NAME
stringlengths 3
254
| SHORTNAME
stringlengths 2
51
⌀ | EXTERNAL_COPYRIGHT_NOTICE
stringlengths 39
2.6k
⌀ | STATUS
stringclasses 4
values | VersionFirstReleased
stringlengths 1
7
| VersionLastChanged
stringlengths 1
5
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
97084-8
|
Effect of Facebook as source of information on mental health
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
Effect of Facebook as source of information on mental health
| null | null |
ACTIVE
|
2.70
|
2.71
|
97085-5
|
Effect of Instagram or Snapchat as source of information on mental health
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
Effect of Instagram or Snapchat as source of information on mental health
| null | null |
ACTIVE
|
2.70
|
2.71
|
97086-3
|
Effect of Twitter as source of information on mental health
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
Effect of Twitter as source of information on mental health
| null | null |
ACTIVE
|
2.70
|
2.71
|
97087-1
|
Effect of social media (e.g., TikTok, Reddit) as source of information on mental health
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
Effect of social media (e.g., TikTok, Reddit) as source of information on mental health
| null | null |
ACTIVE
|
2.70
|
2.71
|
97088-9
|
How often friends, family or neighbors used as source of information for COVID-19
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
How often friends, family or neighbors used as source of information for COVID-19
| null | null |
ACTIVE
|
2.70
|
2.71
|
9708-9
|
Coxiella burnetii phase 1 Ab.IgG
|
Titr
|
Pt
|
Ser
|
Qn
| null |
MICRO
| 1 |
Coxiella burnetii phase 1 IgG Ab [Titer] in Serum
|
C burnet Ph1 IgG Titr Ser
| null |
ACTIVE
|
1.0i
|
2.73
|
97089-7
|
How often medical providers used as source of information for COVID-19
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
How often medical providers used as source of information for COVID-19
| null | null |
ACTIVE
|
2.70
|
2.71
|
97090-5
|
How often local government officials used as source of information for COVID-19
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
How often local government officials used as source of information for COVID-19
| null | null |
ACTIVE
|
2.70
|
2.71
|
97091-3
|
How often Federal Government used as source of information for COVID-19
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
How often Federal Government used as source of information for COVID-19
| null | null |
ACTIVE
|
2.70
|
2.71
|
97092-1
|
How often medical or health websites used as source of information for COVID-19
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
How often medical or health websites used as source of information for COVID-19
| null | null |
ACTIVE
|
2.70
|
2.71
|
97093-9
|
How often print or online news used as source of information for COVID-19
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
How often print or online news used as source of information for COVID-19
| null | null |
ACTIVE
|
2.70
|
2.71
|
97094-7
|
How often TV or radio used as source of information for COVID-19
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
How often TV or radio used as source of information for COVID-19
| null | null |
ACTIVE
|
2.70
|
2.71
|
97095-4
|
How often social media used as source of information for COVID-19
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
How often social media used as source of information for COVID-19
| null | null |
ACTIVE
|
2.70
|
2.71
|
97096-2
|
COVID-19 experiences - media use panel
|
-
|
Pt
|
^Patient
|
-
|
COVEX
|
PANEL.SURVEY.COVID
| 4 |
COVID-19 experiences - media use panel [COVEX]
| null | null |
ACTIVE
|
2.70
|
2.71
|
9709-7
|
Coxiella burnetii phase 2 Ab.IgG
|
Titr
|
Pt
|
Ser
|
Qn
| null |
MICRO
| 1 |
Coxiella burnetii phase 2 IgG Ab [Titer] in Serum
|
C burnet Ph2 IgG Titr Ser
| null |
ACTIVE
|
1.0i
|
2.73
|
97097-0
|
SARS coronavirus 2 Ag
|
PrThr
|
Pt
|
Respiratory.upper
|
Ord
|
IA.rapid
|
MICRO
| 1 |
SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
|
SARS-CoV-2 Ag Upper resp Ql IA.rapid
| null |
ACTIVE
|
2.70
|
2.7
|
97098-8
|
SARS coronavirus 2 Nsp2 gene
|
PrThr
|
Pt
|
Respiratory.upper
|
Ord
|
Probe.amp.tar
|
MICRO
| 1 |
SARS-CoV-2 (COVID-19) Nsp2 gene [Presence] in Upper respiratory specimen by NAA with probe detection
|
SARS-CoV-2 Nsp2 Upper resp Ql NAA+probe
| null |
ACTIVE
|
2.70
|
2.7
|
97099-6
|
Influenza virus A & Influenza virus B & SARS coronavirus 2 Ag panel
|
-
|
Pt
|
Respiratory.upper
|
-
|
IA.rapid
|
PANEL.MICRO
| 1 |
Influenza virus A and B and SARS-CoV-2 (COVID-19) Ag panel - Upper respiratory specimen by Rapid immunoassay
|
FLUABV+SARS-CoV2 Ag Pnl Up resp IA.rapid
| null |
ACTIVE
|
2.70
|
2.7
|
97100-2
|
Colonoscopy and endoscopic ultrasound study
|
Find
|
Pt
|
Lower GI tract
|
Doc
|
Colonoscopy+US
|
ENDO.GI
| 2 |
Colonoscopy+US Study
|
Colonoscopy+US Study
| null |
ACTIVE
|
2.70
|
2.72
|
97101-0
|
Flexible sigmoidoscopy and endoscopic ultrasound study
|
Find
|
Pt
|
Lower GI tract
|
Doc
|
Flexible sigmoidoscopy+US
|
ENDO.GI
| 2 |
Flexible sigmoidoscopy+US Study
|
FSIG+US Study
| null |
ACTIVE
|
2.70
|
2.72
|
97102-8
|
Tau protein.phosphorylated 181/Amyloid beta 42 peptide
|
Ratio
|
Pt
|
CSF
|
Qn
| null |
CHEM
| 1 |
Phosphorylated tau 181/Amyloid beta 42 peptide [Ratio] in Cerebral spinal fluid
|
p-tau181/AL beta42 CSF-Rto
| null |
ACTIVE
|
2.70
|
2.7
|
97103-6
|
Zygosity
|
Type
|
Pt
|
^Fetuses
|
Nom
|
Molgen
|
MOLPATH
| 1 |
Zygosity [Type] in Fetuses by Molecular genetics method
|
Zygosity in Fetuses
| null |
ACTIVE
|
2.70
|
2.7
|
97104-4
|
SARS coronavirus 2 ORF1ab region
|
ACnc
|
Pt
|
Respiratory.upper
|
Qn
|
Probe.amp.tar
|
MICRO
| 1 |
SARS-CoV-2 (COVID-19) ORF1ab region [Units/volume] (viral load) in Upper respiratory specimen by NAA with probe detection
|
SARS-CoV-2 ORF1ab U resp NAA+probe-aCnc
| null |
ACTIVE
|
2.70
|
2.7
|
9710-5
|
Coxiella burnetii phase 1 Ab.IgM
|
Titr
|
Pt
|
Ser
|
Qn
| null |
MICRO
| 1 |
Coxiella burnetii phase 1 IgM Ab [Titer] in Serum
|
C burnet Ph1 IgM Titr Ser
| null |
ACTIVE
|
1.0i
|
2.73
|
97105-1
|
Chemokine (C-C motif) ligand 2
|
MCnc
|
Pt
|
Urine
|
Qn
|
IA
|
CHEM
| 1 |
Chemokine (C-C motif) ligand 2 [Mass/volume] in Urine by Immunoassay
|
CCL2 Ur IA-mCnc
| null |
ACTIVE
|
2.70
|
2.7
|
97106-9
|
Hepatitis A virus cellular receptor 1
|
MCnc
|
Pt
|
Urine
|
Qn
|
IA
|
CHEM
| 1 |
Hepatitis A virus cellular receptor 1 [Mass/volume] in Urine by Immunoassay
|
HAVcr-1 Ur IA-mCnc
| null |
ACTIVE
|
2.70
|
2.7
|
97107-7
|
Fibroblast growth factor 19
|
MCnc
|
Pt
|
Ser/Plas
|
Qn
|
IA
|
CHEM
| 1 |
Fibroblast growth factor 19 [Mass/volume] in Serum or Plasma by Immunoassay
|
FGF-19 SerPl IA-mCnc
| null |
ACTIVE
|
2.70
|
2.7
|
97108-5
|
Employment status in the 2W prior to COVID-19 outbreak
|
Find
|
Pt
|
^Patient
|
Nom
| null |
SURVEY.COVID
| 4 |
Employment status in the 2 weeks prior to COVID-19 outbreak
| null | null |
ACTIVE
|
2.70
|
2.71
|
97109-3
|
New employment during the COVID-19 outbreak
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
New employment during the COVID-19 outbreak
| null | null |
ACTIVE
|
2.70
|
2.71
|
97110-1
|
Work setting in the 2W before the COVID-19 outbreak
|
Find
|
Pt
|
^Patient
|
Nom
| null |
SURVEY.COVID
| 4 |
Work setting in the 2 weeks before the COVID-19 outbreak
| null | null |
ACTIVE
|
2.70
|
2.71
|
97111-9
|
Job loss during the COVID-19 outbreak
|
Find
|
Pt
|
^Patient
|
Nom
| null |
SURVEY.COVID
| 4 |
Job loss during the COVID-19 outbreak
| null | null |
ACTIVE
|
2.70
|
2.71
|
97112-7
|
Worked during the COVID-19 outbreak
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
Worked during the COVID-19 outbreak
| null | null |
ACTIVE
|
2.70
|
2.71
|
9711-3
|
Coxiella burnetii phase 2 Ab.IgM
|
Titr
|
Pt
|
Ser
|
Qn
| null |
MICRO
| 1 |
Coxiella burnetii phase 2 IgM Ab [Titer] in Serum
|
C burnet Ph2 IgM Titr Ser
| null |
ACTIVE
|
1.0i
|
2.73
|
97113-5
|
Significant job changes during the COVID-19 outbreak
|
Find
|
Pt
|
^Patient
|
Nom
| null |
SURVEY.COVID
| 4 |
Significant job changes during the COVID-19 outbreak
| null | null |
ACTIVE
|
2.70
|
2.71
|
97114-3
|
Work setting during the COVID-19 outbreak
|
Find
|
Pt
|
^Patient
|
Nom
| null |
SURVEY.COVID
| 4 |
Work setting during the COVID-19 outbreak
| null | null |
ACTIVE
|
2.70
|
2.71
|
97115-0
|
Student in the few weeks before COVID-19 outbreak
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
Student in the few weeks before COVID-19 outbreak
| null | null |
ACTIVE
|
2.70
|
2.71
|
97116-8
|
Student during the COVID-19 outbreak
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
Student during the COVID-19 outbreak
| null | null |
ACTIVE
|
2.70
|
2.71
|
97117-6
|
School has offered classes remotely during the COVID-19 outbreak
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
School has offered classes remotely during the COVID-19 outbreak
| null | null |
ACTIVE
|
2.70
|
2.71
|
97118-4
|
Increase or decrease in schoolwork during the COVID-19 outbreak
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
Increase or decrease in schoolwork during the COVID-19 outbreak
| null | null |
ACTIVE
|
2.70
|
2.71
|
97119-2
|
Difficulty getting work or schoolwork done because of other responsibilities at home during the COVID-19 outbreak
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
Difficulty getting work or schoolwork done because of other responsibilities at home during the COVID-19 outbreak
| null | null |
ACTIVE
|
2.70
|
2.71
|
971-2
|
Weak D Ag
|
PrThr
|
Pt
|
RBC^Donor
|
Ord
| null |
BLDBK
| 1 |
Weak D Ag [Presence] on Red Blood Cells from Donor
|
Weak D Ag RBC Donr Ql
| null |
ACTIVE
|
1.0
|
2.7
|
97120-0
|
Difficulty getting work or schoolwork done because of your home environment during the COIVD-19 outbreak
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
Difficulty getting work or schoolwork done because of your home environment during the COIVD-19 outbreak
| null | null |
ACTIVE
|
2.70
|
2.71
|
9712-1
|
Shigella boydii Ab
|
Titr
|
Pt
|
Ser
|
Qn
|
Comp fix
|
MICRO
| 1 |
Shigella boydii Ab [Titer] in Serum by Complement fixation
|
S boydii Ab Titr Ser CF
| null |
ACTIVE
|
1.0i
|
2.73
|
97121-8
|
Household job or income loss due to the COVID-19 outbreak
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
Household job or income loss due to the COVID-19 outbreak
| null | null |
ACTIVE
|
2.70
|
2.71
|
97122-6
|
Person who lost job or income due to COVID-19 outbreak
|
Find
|
Pt
|
^Household member
|
Nom
| null |
SURVEY.COVID
| 4 |
Household member who lost job or income due to COVID-19 outbreak
| null | null |
ACTIVE
|
2.70
|
2.71
|
97123-4
|
COVID-19 experiences - employment and school changes panel
|
-
|
Pt
|
^Patient
|
-
|
COVEX
|
PANEL.SURVEY.COVID
| 4 |
COVID-19 experiences - employment and school changes panel [COVEX]
| null | null |
ACTIVE
|
2.70
|
2.71
|
97124-2
|
How helpful has texting, calling or video-calling family members or friends been as a coping strategy during the COVID-19 outbreak
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
How helpful has texting, calling or video-calling family members or friends been as a coping strategy during the COVID-19 outbreak
| null | null |
ACTIVE
|
2.70
|
2.71
|
97125-9
|
How helpful has talking to a therapist been as a coping strategy during the COVID-19 outbreak
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
How helpful has talking to a therapist been as a coping strategy during the COVID-19 outbreak
| null | null |
ACTIVE
|
2.70
|
2.71
|
97126-7
|
How helpful has exercising or walking been as a coping strategy during the COVID-19 outbreak
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
How helpful has exercising or walking been as a coping strategy during the COVID-19 outbreak
| null | null |
ACTIVE
|
2.70
|
2.71
|
97127-5
|
How helpful has cooking or baking been as a coping strategy during the COVID-19 outbreak
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
How helpful has cooking or baking been as a coping strategy during the COVID-19 outbreak
| null | null |
ACTIVE
|
2.70
|
2.71
|
97128-3
|
How helpful have arts and crafts projects been as a coping strategy during the COVID-19 outbreak
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
How helpful have arts and crafts projects been as a coping strategy during the COVID-19 outbreak
| null | null |
ACTIVE
|
2.70
|
2.71
|
97129-1
|
How helpful has cleaning or doing household chores been as a coping strategy during the COVID-19 outbreak
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
How helpful has cleaning or doing household chores been as a coping strategy during the COVID-19 outbreak
| null | null |
ACTIVE
|
2.70
|
2.71
|
97130-9
|
How helpful has playing games with family members been as a coping strategy during the COVID-19 outbreak
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
How helpful has playing games with family members been as a coping strategy during the COVID-19 outbreak
| null | null |
ACTIVE
|
2.70
|
2.71
|
97131-7
|
How helpful has playing online games been as a coping strategy during the COVID-19 outbreak
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
How helpful has playing online games been as a coping strategy during the COVID-19 outbreak
| null | null |
ACTIVE
|
2.70
|
2.71
|
97132-5
|
How helpful has virtual entertainment been as a coping strategy during the COVID-19 outbreak
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
How helpful has virtual entertainment been as a coping strategy during the COVID-19 outbreak
| null | null |
ACTIVE
|
2.70
|
2.71
|
97133-3
|
Helpful coping strategy used during the COVID-19 outbreak
|
Find
|
Pt
|
^Patient
|
Nom
| null |
SURVEY.COVID
| 4 |
Helpful coping strategy used during the COVID-19 outbreak
| null | null |
ACTIVE
|
2.70
|
2.71
|
97134-1
|
How helpful was your coping strategy during the COVID-19 outbreak
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
How helpful was your coping strategy during the COVID-19 outbreak
| null | null |
ACTIVE
|
2.70
|
2.71
|
97135-8
|
Impact of COVID-19 outbreak on life
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
Impact of COVID-19 outbreak on life
| null | null |
ACTIVE
|
2.70
|
2.71
|
97136-6
|
How helpful has texting, calling or video-calling family members or friends been as a coping strategy to your child during the COVID-19 outbreak
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
How helpful has texting, calling or video-calling family members or friends been as a coping strategy to your child during the COVID-19 outbreak
| null | null |
ACTIVE
|
2.70
|
2.71
|
97137-4
|
How helpful has virtual learning or school been as a coping strategy to your child during the COVID-19 outbreak
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
How helpful has virtual learning or school been as a coping strategy to your child during the COVID-19 outbreak
| null | null |
ACTIVE
|
2.70
|
2.71
|
97138-2
|
How helpful has talking to a therapist been as a coping strategy to your child during the COVID-19 outbreak
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
How helpful has talking to a therapist been as a coping strategy to your child during the COVID-19 outbreak
| null | null |
ACTIVE
|
2.70
|
2.71
|
9713-9
|
Shigella dysenteriae Ab
|
Titr
|
Pt
|
Ser
|
Qn
|
Comp fix
|
MICRO
| 1 |
Shigella dysenteriae Ab [Titer] in Serum by Complement fixation
|
S dysenter Ab Titr Ser CF
| null |
ACTIVE
|
1.0i
|
2.73
|
97139-0
|
How helpful has exercising or walking been as a coping strategy to your child during the COVID-19 outbreak
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
How helpful has exercising or walking been as a coping strategy to your child during the COVID-19 outbreak
| null | null |
ACTIVE
|
2.70
|
2.71
|
97140-8
|
How helpful has cooking or baking been as a coping strategy to your child during the COVID-19 outbreak
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
How helpful has cooking or baking been as a coping strategy to your child during the COVID-19 outbreak
| null | null |
ACTIVE
|
2.70
|
2.71
|
97141-6
|
How helpful have arts and crafts projects been as a coping strategy to your child during the COVID-19 outbreak
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
How helpful have arts and crafts projects been as a coping strategy to your child during the COVID-19 outbreak
| null | null |
ACTIVE
|
2.70
|
2.71
|
97142-4
|
How helpful has playing board games, cards with family members been as a coping strategy to your child during the COVID-19 outbreak
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
How helpful has playing board games, cards with family members been as a coping strategy to your child during the COVID-19 outbreak
| null | null |
ACTIVE
|
2.70
|
2.71
|
97143-2
|
How helpful has playing online games been as a coping strategy to your child during the COVID-19 outbreak
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
How helpful has playing online games been as a coping strategy to your child during the COVID-19 outbreak
| null | null |
ACTIVE
|
2.70
|
2.71
|
97144-0
|
How helpful has virtual entertainment been as a coping strategy to your child during the COVID-19 outbreak
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
How helpful has virtual entertainment been as a coping strategy to your child during the COVID-19 outbreak
| null | null |
ACTIVE
|
2.70
|
2.71
|
97145-7
|
Helpful coping strategy your child used during the COVID-19 outbreak
|
Find
|
Pt
|
^Patient
|
Nom
| null |
SURVEY.COVID
| 4 |
Helpful coping strategy your child used during the COVID-19 outbreak
| null | null |
ACTIVE
|
2.70
|
2.71
|
97146-5
|
How helpful was your child's coping strategy during the COVID-19 outbreak
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
How helpful was your child's coping strategy during the COVID-19 outbreak
| null | null |
ACTIVE
|
2.70
|
2.71
|
9714-7
|
Shigella flexneri Ab
|
Titr
|
Pt
|
Ser
|
Qn
|
Comp fix
|
MICRO
| 1 |
Shigella flexneri Ab [Titer] in Serum by Complement fixation
|
S flexneri Ab Titr Ser CF
| null |
ACTIVE
|
1.0i
|
2.73
|
97147-3
|
COVID-19 experiences - coping panel
|
-
|
Pt
|
^Patient
|
-
|
COVEX
|
PANEL.SURVEY.COVID
| 4 |
COVID-19 experiences - coping panel [COVEX]
| null | null |
ACTIVE
|
2.70
|
2.71
|
97148-1
|
Guanidinoacetate
|
SCnc
|
Pt
|
Urine
|
Qn
| null |
CHEM
| 1 |
Guanidinoacetate [Moles/volume] in Urine
|
Guanidinoacetate Ur-sCnc
| null |
ACTIVE
|
2.70
|
2.7
|
97149-9
|
Pro prostate specific Ag isoform 2
|
MCnc
|
Pt
|
Ser/Plas
|
Qn
|
IA
|
CHEM
| 1 |
proPSA isoform 2 [Mass/volume] in Serum or Plasma by Immunoassay
|
proPSA isoform 2 SerPl IA-mCnc
| null |
ACTIVE
|
2.70
|
2.7
|
97150-7
|
Prostate health index
|
Score
|
Pt
|
Ser/Plas
|
Qn
|
Calculated
|
CHEM
| 1 |
Prostate health index in Serum or Plasma by calculation
|
PHI Score SerPl Calc
| null |
ACTIVE
|
2.70
|
2.7
|
97151-5
|
Enterovirus RNA
|
PrThr
|
Pt
|
Ser/Plas
|
Ord
|
Non-probe.amp.tar
|
MICRO
| 1 |
Enterovirus RNA [Presence] in Serum or Plasma by NAA with non-probe detection
|
EV RNA SerPl Ql NAA+non-probe
| null |
ACTIVE
|
2.70
|
2.7
|
97152-3
|
Hepatitis B virus core+little e+p22cr Ag
|
ACnc
|
Pt
|
Ser/Plas
|
Qn
|
IA
|
MICRO
| 1 |
HBc+HBe+p22cr Ag [Units/volume] in Serum or Plasma by Immunoassay
|
HBc+HBe+p22cr Ag SerPl IA-aCnc
| null |
ACTIVE
|
2.70
|
2.7
|
97153-1
|
Primidone
|
PrThr
|
Pt
|
Urine
|
Ord
|
Confirm
|
DRUG/TOX
| 1 |
Primidone [Presence] in Urine by Confirmatory method
|
Primidone Ur Ql Cfm
| null |
ACTIVE
|
2.70
|
2.7
|
9715-4
|
Shigella sonnei Ab
|
Titr
|
Pt
|
Ser
|
Qn
|
Comp fix
|
MICRO
| 1 |
Shigella sonnei Ab [Titer] in Serum by Complement fixation
|
S sonnei Ab Titr Ser CF
| null |
ACTIVE
|
1.0i
|
2.73
|
97154-9
|
Ecgonine methyl ester
|
PrThr
|
Pt
|
Urine
|
Ord
|
Confirm
|
DRUG/TOX
| 1 |
Ecgonine methyl ester [Presence] in Urine by Confirmatory method
|
EME Ur Ql Cfm
| null |
ACTIVE
|
2.70
|
2.7
|
97155-6
|
SARS coronavirus 2 immunization status
|
Hx
|
Pt
|
^Patient
|
Nom
| null |
VACCIN
| 2 |
SARS coronavirus 2 (COVID-19) immunization status
|
SARS-CoV-2 immunization status
| null |
ACTIVE
|
2.70
|
2.7
|
97156-4
|
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA
|
PrThr
|
Pt
|
Genital
|
Ord
|
Probe.amp.sig
|
MICRO
| 1 |
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Genital specimen by Probe with signal amplification
|
HPV I/H Risk DNA Genital Ql Prb+sig amp
| null |
ACTIVE
|
2.70
|
2.7
|
97157-2
|
Human papilloma virus 6+11+42+43+44 DNA
|
PrThr
|
Pt
|
Genital
|
Ord
|
Probe.amp.sig
|
MICRO
| 1 |
Human papilloma virus 6+11+42+43+44 DNA [Presence] in Genital specimen by Probe with signal amplification
|
HPV Low Risk DNA Genital Ql Prb+sig amp
| null |
ACTIVE
|
2.70
|
2.7
|
97158-0
|
Cytokeratin 8 Ag
|
PrThr
|
Pt
|
Tissue
|
Ord
|
Immune stain
|
PATH
| 1 |
Cytokeratin 8 Ag [Presence] in Tissue by Immune stain
|
CK8 Ag tiss Ql ImStn
| null |
ACTIVE
|
2.70
|
2.7
|
97159-8
|
2-Hydroxyethylflurazepam
|
MCnc
|
Pt
|
Urine
|
Qn
|
Confirm
|
DRUG/TOX
| 1 |
2-Hydroxyethylflurazepam [Mass/volume] in Urine by Confirmatory method
|
2-OH-Ethylfluraz Ur Cfm-mCnc
| null |
ACTIVE
|
2.70
|
2.7
|
97160-6
|
Norclobazam
|
MCnc
|
Pt
|
Urine
|
Qn
|
Confirm
|
DRUG/TOX
| 1 |
Norclobazam [Mass/volume] in Urine by Confirmatory method
|
Norclobazam Ur Cfm-mCnc
| null |
ACTIVE
|
2.70
|
2.7
|
97161-4
|
Amphetamines panel
|
-
|
Pt
|
Urine
|
-
|
Confirm
|
PANEL.DRUG/TOX
| 1 |
Amphetamines panel - Urine by Confirmatory method
|
Amphetamines Pnl Ur Cfm
| null |
ACTIVE
|
2.70
|
2.7
|
9716-2
|
Streptococcal hyaluronidase Ab
|
Titr
|
Pt
|
Ser
|
Qn
| null |
MICRO
| 1 |
Streptococcal hyaluronidase Ab [Titer] in Serum
|
Str Hyaluronidase Ab Titr Ser
| null |
ACTIVE
|
1.0i
|
2.7
|
97162-2
|
Titin Ab
|
ACnc
|
Pt
|
CSF
|
Qn
|
Line blot
|
SERO
| 1 |
Titin Ab [Units/volume] in Cerebral spinal fluid by Line blot
|
Titin Ab CSF Line blot-aCnc
| null |
ACTIVE
|
2.70
|
2.7
|
97163-0
|
Theophylline^peak
|
MCnc
|
Pt
|
Ser/Plas
|
Qn
| null |
DRUG/TOX
| 1 |
Theophylline [Mass/volume] in Serum or Plasma --peak
|
Theophylline Peak SerPl-mCnc
| null |
ACTIVE
|
2.70
|
2.7
|
97164-8
|
Triiodothyronine
|
MRat
|
24H
|
Urine
|
Qn
| null |
CHEM
| 1 |
Triiodothyronine (T3) [Mass/time] in 24 hour Urine
|
T3 24h Ur-mRate
| null |
ACTIVE
|
2.70
|
2.7
|
97165-5
|
Triiodothyronine
|
SRat
|
24H
|
Urine
|
Qn
| null |
CHEM
| 1 |
Triiodothyronine (T3) [Moles/time] in 24 hour Urine
|
T3 24h Ur-sRate
| null |
ACTIVE
|
2.70
|
2.7
|
97166-3
|
Thyroxine
|
MRat
|
24H
|
Urine
|
Qn
| null |
CHEM
| 1 |
Thyroxine (T4) [Mass/time] in 24 hour Urine
|
T4 24h Ur-mRate
| null |
ACTIVE
|
2.70
|
2.7
|
97167-1
|
Thyroxine
|
SRat
|
24H
|
Urine
|
Qn
| null |
CHEM
| 1 |
Thyroxine (T4) [Moles/time] in 24 hour Urine
|
T4 24h Ur-sRate
| null |
ACTIVE
|
2.70
|
2.7
|
97168-9
|
Vasopressin
|
MRat
|
24H
|
Urine
|
Qn
| null |
CHEM
| 1 |
Vasopressin [Mass/time] in 24 hour Urine
|
Vasopressin 24h Ur-mRate
| null |
ACTIVE
|
2.70
|
2.7
|
97169-7
|
Vasopressin
|
SRat
|
24H
|
Urine
|
Qn
| null |
CHEM
| 1 |
Vasopressin [Moles/time] in 24 hour Urine
|
Vasopressin 24h Ur-sRate
| null |
ACTIVE
|
2.70
|
2.7
|
9717-0
|
Toxocara canis Ab.IgA
|
ACnc
|
Pt
|
Ser
|
Qn
|
IA
|
MICRO
| 1 |
Toxocara canis IgA Ab [Units/volume] in Serum by Immunoassay
|
T canis IgA Ser IA-aCnc
| null |
ACTIVE
|
1.0i
|
2.68
|
97170-5
|
Adalimumab^trough
|
MCnc
|
Pt
|
Ser/Plas
|
Qn
| null |
DRUG/TOX
| 1 |
Adalimumab [Mass/volume] in Serum or Plasma --trough
|
Adalimumab Trough SerPl-mCnc
| null |
ACTIVE
|
2.70
|
2.7
|
97171-3
|
Hexacarboxylporphyrin/Creatinine
|
SRto
|
Pt
|
Urine
|
Qn
| null |
CHEM
| 1 |
Hexacarboxylporphyrin/Creatinine [Molar ratio] in Urine
|
Hexa-CP/Creat Ur-sRto
| null |
ACTIVE
|
2.70
|
2.7
|
97172-1
|
Yersinia outer protein Ab panel
|
-
|
Pt
|
Ser
|
-
|
Line blot
|
PANEL.MICRO
| 1 |
Yersinia outer protein Ab panel - Serum by Line blot
|
Yop Ab Pnl Ser Line blot
| null |
ACTIVE
|
2.70
|
2.7
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.